These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 26132520)
1. Horses for courses: reaching outside drug-like chemical space for inhibitors of challenging drug targets. Whitty A; Zhou L Future Med Chem; 2015; 7(9):1093-5. PubMed ID: 26132520 [No Abstract] [Full Text] [Related]
2. Building upon Nature's Framework: Overview of Key Strategies Toward Increasing Drug-Like Properties of Natural Product Cyclopeptides and Macrocycles. Blanco MJ Methods Mol Biol; 2019; 2001():203-233. PubMed ID: 31134573 [TBL] [Abstract][Full Text] [Related]
3. Oral druggable space beyond the rule of 5: insights from drugs and clinical candidates. Doak BC; Over B; Giordanetto F; Kihlberg J Chem Biol; 2014 Sep; 21(9):1115-42. PubMed ID: 25237858 [TBL] [Abstract][Full Text] [Related]
4. Macrocyclic drugs and clinical candidates: what can medicinal chemists learn from their properties? Giordanetto F; Kihlberg J J Med Chem; 2014 Jan; 57(2):278-95. PubMed ID: 24044773 [TBL] [Abstract][Full Text] [Related]
5. Macrocycles: MCR synthesis and applications in drug discovery. Abdelraheem EMM; Shaabani S; Dömling A Drug Discov Today Technol; 2018 Nov; 29():11-17. PubMed ID: 30471668 [TBL] [Abstract][Full Text] [Related]
7. Construction and screening of vast libraries of natural product-like macrocyclic peptides using in vitro display technologies. Bashiruddin NK; Suga H Curr Opin Chem Biol; 2015 Feb; 24():131-8. PubMed ID: 25483262 [TBL] [Abstract][Full Text] [Related]
8. The exploration of macrocycles for drug discovery--an underexploited structural class. Driggers EM; Hale SP; Lee J; Terrett NK Nat Rev Drug Discov; 2008 Jul; 7(7):608-24. PubMed ID: 18591981 [TBL] [Abstract][Full Text] [Related]
9. Lead discovery and optimization strategies for peptide macrocycles. Bhat A; Roberts LR; Dwyer JJ Eur J Med Chem; 2015 Apr; 94():471-9. PubMed ID: 25109255 [TBL] [Abstract][Full Text] [Related]
10. Synthesis of the macrocyclic core of rhizopodin. Song L; Liu J; Gui H; Hui C; Zhou J; Guo Y; Zhang P; Xu Z; Ye T Chem Asian J; 2013 Dec; 8(12):2955-9. PubMed ID: 24038898 [No Abstract] [Full Text] [Related]
11. Druggability assessment of protein-protein interfaces. Wanner J; Fry DC; Peng Z; Roberts J Future Med Chem; 2011 Dec; 3(16):2021-38. PubMed ID: 22098351 [TBL] [Abstract][Full Text] [Related]
12. Natural product-like macrocyclic N-methyl-peptide inhibitors against a ubiquitin ligase uncovered from a ribosome-expressed de novo library. Yamagishi Y; Shoji I; Miyagawa S; Kawakami T; Katoh T; Goto Y; Suga H Chem Biol; 2011 Dec; 18(12):1562-70. PubMed ID: 22195558 [TBL] [Abstract][Full Text] [Related]
14. Macrocycles in Drug Discovery─Learning from the Past for the Future. Garcia Jimenez D; Poongavanam V; Kihlberg J J Med Chem; 2023 Apr; 66(8):5377-5396. PubMed ID: 37017513 [TBL] [Abstract][Full Text] [Related]
15. Development of a natural-product-derived chemical toolbox for modulation of protein function. Rizzo S; Waldmann H Chem Rev; 2014 May; 114(9):4621-39. PubMed ID: 24568160 [No Abstract] [Full Text] [Related]
16. Molecular diversity in the context of leadlikeness: compound properties that enable effective biochemical screening. Rishton GM Curr Opin Chem Biol; 2008 Jun; 12(3):340-51. PubMed ID: 18328272 [TBL] [Abstract][Full Text] [Related]
18. Unique macrocycles in the Taiwan traditional Chinese medicine database. Kramer C; Podewitz M; Ertl P; Liedl KR Planta Med; 2015 Apr; 81(6):459-66. PubMed ID: 25856438 [TBL] [Abstract][Full Text] [Related]
19. Modern natural products chemistry and drug discovery. Ojima I J Med Chem; 2008 May; 51(9):2587-8. PubMed ID: 18393400 [No Abstract] [Full Text] [Related]
20. Drug Syntheses Beyond the Rule of 5. Tyagi M; Begnini F; Poongavanam V; Doak BC; Kihlberg J Chemistry; 2020 Jan; 26(1):49-88. PubMed ID: 31483909 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]